Oppenheimer Asset Management’s Emergent Biosolutions EBS Stock Holding History

Oppenheimer Asset Management’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$265K	Buy	+31,647	New	+$265K	﹤0.01%	1027
2022 Q3	–	Sell	-36,326	Closed	-$1.13M	–	1135
2022 Q2	$1.13M	Sell	36,326 -1,238	-3%	-$42.3K	0.02%	638
2022 Q1	$1.54M	Buy	37,564 +4,226	+13%	+$186K	0.02%	611
2021 Q4	$1.45M	Sell	33,338 -3,494	-9%	-$158K	0.02%	655
2021 Q3	$1.84M	Buy	36,832 +168	+0.5%	+$10.2K	0.03%	563
2021 Q2	$2.31M	Buy	36,664 +9,891	+37%	+$635K	0.03%	482
2021 Q1	$2.49M	Buy	26,773 +2,237	+9%	+$229K	0.04%	450
2020 Q4	$2.2M	Buy	24,536 +28	+0.1%	+$2.57K	0.04%	461
2020 Q3	$2.53M	Sell	24,508 -22,506	-48%	-$2.43M	0.05%	376
2020 Q2	$3.72M	Buy	47,014 +6,606	+16%	+$492K	0.08%	285
2020 Q1	$2.34M	Buy	40,408 +4,646	+13%	+$268K	0.06%	316
2019 Q4	$1.93M	Sell	35,762 -274	-0.8%	-$14.9K	0.04%	420
2019 Q3	$1.88M	Sell	36,036 -677	-2%	-$31.5K	0.04%	423
2019 Q2	$1.77M	Buy	+36,713	New	+$1.76M	0.04%	440

Other funds holding EBS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

OHA

Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Oppenheimer Asset Management's EBS Position: Q2 2026 in Review

Oppenheimer Asset Management opened a new position in Emergent Biosolutions (EBS) in Q2 2026: 31,647 shares worth $265K. The stake represents ﹤0.01% of the portfolio and ranks #1027 among its holdings. This is a return to the name: Oppenheimer Asset Management previously reported a position in EBS as recently as Q2 2022.

Oppenheimer Asset Management first reported a position in EBS in Q2 2019 and has held it in 14 quarters since. The position peaked at $3.72M in Q2 2020. 194 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

Oppenheimer Asset Management held 31,647 shares of Emergent Biosolutions worth $265K as of Q2 2026.
Emergent Biosolutions was a new Oppenheimer Asset Management position in Q2 2026.
Emergent Biosolutions made up ﹤0.01% of Oppenheimer Asset Management's portfolio in Q2 2026, its #1027 holding.
Oppenheimer Asset Management first reported a position in Emergent Biosolutions in Q2 2019 and has held it in 14 quarters since.
Oppenheimer Asset Management's Emergent Biosolutions position peaked at $3.72M in Q2 2020.
194 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Oppenheimer Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.